ADELPHI, Md. — Federal health advisers said Monday that patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.A panel of Food and Drug Administration experts voted 15-1, with one abstention, to maintain the drugs' approval for patients with chronic kidney disease who are not yet sick enough to receive dialysis.